
### [MONDO:0017037](http://purl.obolibrary.org/obo/MONDO_0017037)
**Label:** secondary interstitial lung disease in childhood and adulthood associated with a metabolic disease

**Subclasses:** [MONDO:0009265](http://purl.obolibrary.org/obo/MONDO_0009265) (Gaucher's disease type i), [MONDO:0018982](http://purl.obolibrary.org/obo/MONDO_0018982) (Niemann-Pick disease type C), [MONDO:0016310](http://purl.obolibrary.org/obo/MONDO_0016310) (Niemann-Pick disease type C, adult neurologic onset), [MONDO:0016309](http://purl.obolibrary.org/obo/MONDO_0016309) (Niemann-Pick disease type C, juvenile neurologic onset), [MONDO:0011873](http://purl.obolibrary.org/obo/MONDO_0011873) (Niemann-Pick disease, type C2), [MONDO:0016306](http://purl.obolibrary.org/obo/MONDO_0016306) (Niemann-Pick disease type C, severe perinatal form), [MONDO:0009757](http://purl.obolibrary.org/obo/MONDO_0009757) (Niemann-Pick disease, type C1), [MONDO:0016308](http://purl.obolibrary.org/obo/MONDO_0016308) (Niemann-Pick disease type C, late infantile neurologic onset), [MONDO:0016307](http://purl.obolibrary.org/obo/MONDO_0016307) (Niemann-Pick disease type C, severe early infantile neurologic onset), 

**Corr. equiv. classes:** [OMIM:607625](http://purl.obolibrary.org/obo/OMIM_607625), [Orphanet:216981](http://www.orpha.net/ORDO/Orphanet_216981), [OMIM:230800](http://purl.obolibrary.org/obo/OMIM_230800), [Orphanet:216972](http://www.orpha.net/ORDO/Orphanet_216972), [Orphanet:646](http://www.orpha.net/ORDO/Orphanet_646), [OMIM:257220](http://purl.obolibrary.org/obo/OMIM_257220), [Orphanet:77259](http://www.orpha.net/ORDO/Orphanet_77259), [Orphanet:216986](http://www.orpha.net/ORDO/Orphanet_216986), [Orphanet:216975](http://www.orpha.net/ORDO/Orphanet_216975), [Orphanet:216978](http://www.orpha.net/ORDO/Orphanet_216978), 

**Class expressions from DL-Learner:**

- [HP:0001005](http://purl.obolibrary.org/obo/HP_0001005) (Dermatological manifestations of systemic disorders) and [HP:0001251](http://purl.obolibrary.org/obo/HP_0001251) (Ataxia) and [HP:0001541](http://purl.obolibrary.org/obo/HP_0001541) (Ascites) and [HP:0025270](http://purl.obolibrary.org/obo/HP_0025270) (Abnormality of esophagus physiology) 65.00%
- [HP:0001005](http://purl.obolibrary.org/obo/HP_0001005) (Dermatological manifestations of systemic disorders) and [HP:0001251](http://purl.obolibrary.org/obo/HP_0001251) (Ataxia) and [HP:0001541](http://purl.obolibrary.org/obo/HP_0001541) (Ascites) and [HP:0012719](http://purl.obolibrary.org/obo/HP_0012719) (Functional abnormality of the gastrointestinal tract) 65.00%
- [HP:0001005](http://purl.obolibrary.org/obo/HP_0001005) (Dermatological manifestations of systemic disorders) and [HP:0001251](http://purl.obolibrary.org/obo/HP_0001251) (Ataxia) and [HP:0001541](http://purl.obolibrary.org/obo/HP_0001541) (Ascites) and [HP:0002015](http://purl.obolibrary.org/obo/HP_0002015) (Dysphagia) 65.00%
- [HP:0001005](http://purl.obolibrary.org/obo/HP_0001005) (Dermatological manifestations of systemic disorders) and [HP:0001251](http://purl.obolibrary.org/obo/HP_0001251) (Ataxia) and [HP:0001332](http://purl.obolibrary.org/obo/HP_0001332) (Dystonia) and [HP:0001541](http://purl.obolibrary.org/obo/HP_0001541) (Ascites) 65.00%
- [HP:0000952](http://purl.obolibrary.org/obo/HP_0000952) (Jaundice) and [HP:0001251](http://purl.obolibrary.org/obo/HP_0001251) (Ataxia) and [HP:0001541](http://purl.obolibrary.org/obo/HP_0001541) (Ascites) and [HP:0025270](http://purl.obolibrary.org/obo/HP_0025270) (Abnormality of esophagus physiology) 65.00%
- [HP:0000952](http://purl.obolibrary.org/obo/HP_0000952) (Jaundice) and [HP:0001251](http://purl.obolibrary.org/obo/HP_0001251) (Ataxia) and [HP:0001541](http://purl.obolibrary.org/obo/HP_0001541) (Ascites) and [HP:0012719](http://purl.obolibrary.org/obo/HP_0012719) (Functional abnormality of the gastrointestinal tract) 65.00%
- [HP:0000952](http://purl.obolibrary.org/obo/HP_0000952) (Jaundice) and [HP:0001251](http://purl.obolibrary.org/obo/HP_0001251) (Ataxia) and [HP:0001541](http://purl.obolibrary.org/obo/HP_0001541) (Ascites) and [HP:0002015](http://purl.obolibrary.org/obo/HP_0002015) (Dysphagia) 65.00%
- [HP:0000952](http://purl.obolibrary.org/obo/HP_0000952) (Jaundice) and [HP:0001251](http://purl.obolibrary.org/obo/HP_0001251) (Ataxia) and [HP:0001332](http://purl.obolibrary.org/obo/HP_0001332) (Dystonia) and [HP:0001541](http://purl.obolibrary.org/obo/HP_0001541) (Ascites) 65.00%
- [HP:0000708](http://purl.obolibrary.org/obo/HP_0000708) (Behavioral abnormality) and [HP:0001005](http://purl.obolibrary.org/obo/HP_0001005) (Dermatological manifestations of systemic disorders) and [HP:0001251](http://purl.obolibrary.org/obo/HP_0001251) (Ataxia) and [HP:0001541](http://purl.obolibrary.org/obo/HP_0001541) (Ascites) 65.00%
- [HP:0000708](http://purl.obolibrary.org/obo/HP_0000708) (Behavioral abnormality) and [HP:0000952](http://purl.obolibrary.org/obo/HP_0000952) (Jaundice) and [HP:0001251](http://purl.obolibrary.org/obo/HP_0001251) (Ataxia) and [HP:0001541](http://purl.obolibrary.org/obo/HP_0001541) (Ascites) 65.00%
- [HP:0001005](http://purl.obolibrary.org/obo/HP_0001005) (Dermatological manifestations of systemic disorders) and [HP:0001251](http://purl.obolibrary.org/obo/HP_0001251) (Ataxia) and [HP:0001541](http://purl.obolibrary.org/obo/HP_0001541) (Ascites) and [HP:0100543](http://purl.obolibrary.org/obo/HP_0100543) (Cognitive impairment) and [HP:0100763](http://purl.obolibrary.org/obo/HP_0100763) (Abnormality of the lymphatic system) 65.00%
- [HP:0001005](http://purl.obolibrary.org/obo/HP_0001005) (Dermatological manifestations of systemic disorders) and [HP:0001251](http://purl.obolibrary.org/obo/HP_0001251) (Ataxia) and [HP:0001541](http://purl.obolibrary.org/obo/HP_0001541) (Ascites) and [HP:0025408](http://purl.obolibrary.org/obo/HP_0025408) (Abnormal spleen morphology) and [HP:0100543](http://purl.obolibrary.org/obo/HP_0100543) (Cognitive impairment) 65.00%
- [HP:0001005](http://purl.obolibrary.org/obo/HP_0001005) (Dermatological manifestations of systemic disorders) and [HP:0001251](http://purl.obolibrary.org/obo/HP_0001251) (Ataxia) and [HP:0001541](http://purl.obolibrary.org/obo/HP_0001541) (Ascites) and [HP:0025270](http://purl.obolibrary.org/obo/HP_0025270) (Abnormality of esophagus physiology) and [HP:0100543](http://purl.obolibrary.org/obo/HP_0100543) (Cognitive impairment) 65.00%
- [HP:0001005](http://purl.obolibrary.org/obo/HP_0001005) (Dermatological manifestations of systemic disorders) and [HP:0001251](http://purl.obolibrary.org/obo/HP_0001251) (Ataxia) and [HP:0001541](http://purl.obolibrary.org/obo/HP_0001541) (Ascites) and [HP:0025270](http://purl.obolibrary.org/obo/HP_0025270) (Abnormality of esophagus physiology) and [HP:0025408](http://purl.obolibrary.org/obo/HP_0025408) (Abnormal spleen morphology) 65.00%
- [HP:0001005](http://purl.obolibrary.org/obo/HP_0001005) (Dermatological manifestations of systemic disorders) and [HP:0001251](http://purl.obolibrary.org/obo/HP_0001251) (Ataxia) and [HP:0001541](http://purl.obolibrary.org/obo/HP_0001541) (Ascites) and [HP:0025032](http://purl.obolibrary.org/obo/HP_0025032) (Abnormality of digestive system physiology) and [HP:0025408](http://purl.obolibrary.org/obo/HP_0025408) (Abnormal spleen morphology) 65.00%


